Fulgent Genetics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Fulgent Genetics, Inc. on May 27, 2020. The report details the results of the Company's Annual Meeting of Stockholders held on the same date at its offices in El Monte, California. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and stockholder voting results.
Material Changes and Voting Results
As of the record date (April 4, 2020), 21,672,192 shares of common stock were outstanding. A quorum of approximately 92% (19,879,242 shares) was present at the meeting. Stockholders voted on two proposals:
- Proposal 1 (Election of Directors): Four directors were elected to one-year terms. All nominees received significant majority support:
- Ming Hsieh: 14,514,351 For, 77,175 Withheld
- John Bolger: 14,440,996 For, 150,530 Withheld
- Yun Yen, M.D., Ph.D., F.A.C.P.: 13,823,351 For, 768,175 Withheld
- Linda Marsh: 14,542,174 For, 49,352 Withheld
- Proposal 2 (Ratification of Auditors): Stockholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2020.
- For: 19,841,133
- Against: 33,784
- Abstain: 4,325
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management commentary on future outlook, specific risks, contingencies, or unusual items. The document is limited to the reporting of the Annual Meeting vote outcomes.
Key Facts for Investor Verification
- Confirmation that the four nominated directors (Ming Hsieh, John Bolger, Yun Yen, and Linda Marsh) have officially assumed their roles for the 2020-2021 term.
- Verification of the high level of stockholder engagement, with 92% of outstanding shares represented at the meeting.
- Confirmation that Deloitte & Touche LLP is the appointed auditor for the fiscal year ending December 31, 2020.
- Review of the Company's most recent 10-K or 10-Q filings for financial performance data, as this 8-K contains no financial metrics.